Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6170)
All Articles published online
|
Publishing Process of This Article
|
Apr 21, 2014 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Miyahara K, Nouso K, Yamamoto K. Chemotherapy for advanced hepatocellular carcinoma in the sorafenib age. World J Gastroenterol 2014; 20(15): 4151-4159 [PMID: 24764653 DOI: 10.3748/wjg.v20.i15.4151] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i15/4151.htm |
| Number | Citing Articles |
| 1 |
Rubens Copia Sperandio, Roberto Carmagnani Pestana, Beatriz Viesser Miyamura, Ahmed O. Kaseb. Hepatocellular Carcinoma Immunotherapy. Annual Review of Medicine 2022; 73(1): 267 doi: 10.1146/annurev-med-042220-021121
|
| 2 |
Roberto Mazzanti, Umberto Arena, Renato Tassi. Hepatocellular carcinoma: Where are we?. World Journal of Experimental Medicine 2016; 6(1): 21-36 doi: 10.5493/wjem.v6.i1.21
|
| 3 |
Takuji Okusaka, Taiga Otsuka, Hideki Ueno, Shuichi Mitsunaga, Rie Sugimoto, Kei Muro, Isao Saito, Yusuke Tadayasu, Kohei Inoue, Arsene‐Bienvenu Loembé, Masafumi Ikeda. Phase I study of nintedanib in Japanese patients with advanced hepatocellular carcinoma and liver impairment. Cancer Science 2016; 107(12): 1791 doi: 10.1111/cas.13077
|
| 4 |
Xing Yuan, Hao Chen, Xia Li, Ming Dai, Huawu Zeng, Lei Shan, Qingyan Sun, Weidong Zhang. Inhibition of protein kinase C by isojacareubin suppresses hepatocellular carcinoma metastasis and induces apoptosis in vitro and in vivo. Scientific Reports 2015; 5(1) doi: 10.1038/srep12889
|
| 5 |
QI-WEN CHEN, WEN-JING TENG, QIAN CHEN. Chest wall hernia induced by high intensity focused ultrasound treatment of unresectable massive hepatocellular carcinoma: A case report. Oncology Letters 2016; 12(1): 627 doi: 10.3892/ol.2016.4618
|
| 6 |
Aparna Kalyan, Halla Nimeiri, Laura Kulik. Systemic Therapy of Hepatocellular Carcinoma. Clinics in Liver Disease 2015; 19(2): 421 doi: 10.1016/j.cld.2015.01.009
|
| 7 |
Qing-Qiang Shi, Guo-Wei Zuo, Zi-Qiang Feng, Lv-Cui Zhao, Lian Luo, Zhi-Mei You, Dang-Yang Li, Jing Xia, Jing Li, Di-Long Chen. Effect of Trichostatin A on Anti HepG2 Liver Carcinoma Cells: Inhibition of HDAC Activity and Activation of Wnt/β-Catenin Signaling. Asian Pacific Journal of Cancer Prevention 2014; 15(18): 7849 doi: 10.7314/APJCP.2014.15.18.7849
|
| 8 |
Qingye Yang, Chaohui Zhou, Qi Zhao, Zhongyun Chu, Da-Peng Yang, Nengqin Jia. Sonochemical assisted synthesis of dual functional BSA nanoparticle for the removal of excessive bilirubin and strong anti-tumor effects. Materials Science and Engineering: C 2019; 100: 688 doi: 10.1016/j.msec.2019.03.042
|
| 9 |
Qingqiang Shi, Xueping Shi, Gei Zuo, Wei Xiong, Haixing Li, Pei Guo, Fen Wang, Yi Chen, Jing Li, Di-Long Chen. Anticancer effect of 20(S)-ginsenoside Rh2 on HepG2 liver carcinoma cells: Activating GSK-3β and degrading β-catenin. Oncology Reports 2016; 36(4): 2059 doi: 10.3892/or.2016.5033
|
| 10 |
Tasneem Abaza, Mostafa K. Abd El-Aziz, Kerolos Ashraf Daniel, Paraskevi Karousi, Maria Papatsirou, Sherif Ashraf Fahmy, Nadia M. Hamdy, Christos K. Kontos, Rana A. Youness. Emerging Role of Circular RNAs in Hepatocellular Carcinoma Immunotherapy. International Journal of Molecular Sciences 2023; 24(22): 16484 doi: 10.3390/ijms242216484
|
| 11 |
Jiang Chen, Renan Jin, Jie Zhao, Jinghua Liu, Hanning Ying, Han Yan, Senjun Zhou, Yuelong Liang, Diyu Huang, Xiao Liang, Hong Yu, Hui Lin, Xiujun Cai. Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma. Cancer Letters 2015; 367(1): 1 doi: 10.1016/j.canlet.2015.06.019
|
| 12 |
Adam Doyle, Morris Sherman. Sherlock's Diseases of the Liver and Biliary System. 2018; : 705 doi: 10.1002/9781119237662.ch36
|
| 13 |
Hany A. Omar, Dana M. Zaher, Vunnam Srinivasulu, Fatema Hersi, Hamadeh Tarazi, Taleb H. Al-Tel. Design, synthesis and biological evaluation of new pyrrolidine carboxamide analogues as potential chemotherapeutic agents for hepatocellular carcinoma. European Journal of Medicinal Chemistry 2017; 139: 804 doi: 10.1016/j.ejmech.2017.08.054
|
| 14 |
Song Shen, Chun-Yang Sun, Xiao-Jiao Du, Hong-Jun Li, Yang Liu, Jin-Xing Xia, Yan-Hua Zhu, Jun Wang. Co-delivery of platinum drug and siNotch1 with micelleplex for enhanced hepatocellular carcinoma therapy. Biomaterials 2015; 70: 71 doi: 10.1016/j.biomaterials.2015.08.026
|
| 15 |
Xinjun Dong, Feiyan Liu, Mianli Li. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells. Anti-Cancer Drugs 2016; 27(4): 286 doi: 10.1097/CAD.0000000000000329
|
| 16 |
Amir Mehdizadeh, Mohammad Hossein Somi, Masoud Darabi, Safar Farajnia, Abolfazl Akbarzadeh, Soheila Montazersaheb, Mehdi Yousefi, Mortaza Bonyadi. Liposome-mediated RNA interference delivery against Erk1 and Erk2 does not equally promote chemosensitivity in human hepatocellular carcinoma cell line HepG2. Artificial Cells, Nanomedicine, and Biotechnology 2017; 45(8): 1612 doi: 10.1080/21691401.2016.1269117
|
| 17 |
Sahabjada Siddiqui, Rumana Ahmad, Mohsin Ali Khan, Shivbrat Upadhyay, Ishrat Husain, Anand Narain Srivastava. Cytostatic and Anti-tumor Potential of Ajwa Date Pulp against Human Hepatocellular Carcinoma HepG2 Cells. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-018-36475-0
|
| 18 |
Femke Heindryckx, Pär Gerwins. Targeting the tumor stroma in hepatocellular carcinoma. World Journal of Hepatology 2015; 7(2): 165-176 doi: 10.4254/wjh.v7.i2.165
|
| 19 |
Rubens Copia Sperandio, Roberto Carmagnani Pestana, Ahmed O. Kaseb. The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases. 2022; : 177 doi: 10.1007/978-981-19-0063-1_21
|
| 20 |
Miko Kawabata, Noriko Umemoto, Yasuhito Shimada, Yuhei Nishimura, Beibei Zhang, Junya Kuroyanagi, Masayuki Miyabe, Toshio Tanaka. Downregulation of Stanniocalcin 1 Is Responsible for Sorafenib-Induced Cardiotoxicity. Toxicological Sciences 2015; 143(2): 374 doi: 10.1093/toxsci/kfu235
|
| 21 |
Stefano Colagrande, Francesco Regini, Gian Giacomo Taliani, Cosimo Nardi, Andrea Lorenzo Inghilesi. Advanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-up. World Journal of Hepatology 2015; 7(8): 1041-1053 doi: 10.4254/wjh.v7.i8.1041
|
| 22 |
Da Yi, Yalda Yazdani. Mitochondria-Targeting-Based of Paclitaxel-Loaded Triphenylphosphine-Pluronic F127-Hyaluronic Acid Nanomicelles in Multi-Drug Resistant Hepatocellular Carcinoma. Journal of Biomedical Nanotechnology 2022; 18(5): 1325 doi: 10.1166/jbn.2022.3339
|
| 23 |
Boris J. B. Beudeker, Andre Boonstra. Circulating biomarkers for early detection of hepatocellular carcinoma. Therapeutic Advances in Gastroenterology 2020; 13: 175628482093173 doi: 10.1177/1756284820931734
|
| 24 |
Hao Chen, Xiao Yang, Zongmin Yu, Ziying Cheng, Hu Yuan, Zeng Zhao, Guozhen Wu, Ning Xie, Xing Yuan, Qingyan Sun, Weidong Zhang. Synthesis and biological evaluation of α -santonin derivatives as anti-hepatoma agents. European Journal of Medicinal Chemistry 2018; 149: 90 doi: 10.1016/j.ejmech.2018.02.073
|
| 25 |
Tae Ho Hong, M. T. Jeena, Ok-Hee Kim, Kee-Hwan Kim, Ho Joong Choi, Kyung Hee Lee, Ha-Eun Hong, Ja-Hyoung Ryu, Say-June Kim. Application of self-assembly peptides targeting the mitochondria as a novel treatment for sorafenib-resistant hepatocellular carcinoma cells. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-020-79536-z
|